Hum. Mol. Genet. (2011) doi: 10.1093/hmg/ddr187
Gloria M. Palomo 1,2, Toñi Cerrato 1,2, Ricardo Gargini1 and Javier Díaz-Nido 1,2
1 Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa” (UAM-CSIC), C/ Nicolás Cabrera, 1. Campus de Cantoblanco. Universidad Autónoma de Madrid. 28049 Madrid, Spain
2 CIBER de Enfermedades Raras (CIBERER). 28049 Madrid, Spain
Keywords: Friedreich’s ataxia, frataxin, neuronal cells, lentiviral vectors, minigenes, frataxin-specific shRNAs, human neuroblastoma SH-SY5Y cells, p53, PUMA, Bax, caspase-3, autophagy, useful cell model, neurodegeneration.
Friday, April 29, 2011
European regulation on orphan medicinal products: 10 years of experience and future perspectives
Nature Reviews Drug Discovery 10, 341-349 (May 2011) | doi:10.1038/nrd3445
The Committee for Orphan Medicinal Products and the European Medicines Agency. Scientific Secretariat 1
Keywords: orphan medicinal products, European Union, rare conditions, orphan drug designations, Committee for Orphan Medicinal Products (COMP), marketing authorization in Europe.
Subscribe to:
Posts (Atom)